KCM
ASPN icon

KRS Capital Management’s Aspen Aerogels ASPN Stock Holding History

KRS Capital Management’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,700
Closed -$134K – 139
2021
Q4 		$134K Buy
+2,700
New +$142K 0.11% 149

Other funds holding ASPN

SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

KRS Capital Management's ASPN Position: Q1 2022 in Review

KRS Capital Management sold out of Aspen Aerogels (ASPN) in Q1 2022, closing a stake of 2,700 shares — an estimated $134K sold.

KRS Capital Management first reported a position in ASPN in Q4 2021 and held it in 1 quarter. The position peaked at $134K in Q4 2021. 145 funds tracked by Wall St. Rank hold ASPN as of Q1 2022.

  • KRS Capital Management reported no remaining Aspen Aerogels position as of Q1 2022 after selling out during the quarter.
  • KRS Capital Management sold 2,700 Aspen Aerogels shares in Q1 2022, an estimated $134K.
  • KRS Capital Management first reported a position in Aspen Aerogels in Q4 2021 and held it in 1 quarter.
  • KRS Capital Management's Aspen Aerogels position peaked at $134K in Q4 2021.
  • 145 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2022.

Based on KRS Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.